Last reviewed · How we verify

NCT05587764

Tempus Pro Monitor Registry

Completed Last updated 10 March 2025
What this trial tests

trial testing Standard of Care in Sudden Cardiac Arrest in 103 participants. Completed in 12 August 2024.

Timeline
25 April 2024
Primary endpoint
12 August 2024
12 August 2024

Quick facts

Lead sponsorPhilips Clinical & Medical Affairs Global
StatusCompleted
Study typeOBSERVATIONAL
Enrollment103
Start date25 April 2024
Primary completion12 August 2024
Estimated completion12 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Philips Clinical & Medical Affairs Global — full company profile →

Who can join

Eligibility, any sex, with Sudden Cardiac Arrest or Emergency Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multicenter, prospective and retrospective, observational, post market study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Standard of Care

Trials testing the same drug.

Other recruiting trials for Sudden Cardiac Arrest

Currently open trials in the same condition.

Other Philips Clinical & Medical Affairs Global trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05587764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing